NLS Pharmaceutics Total Asset vs. Market Capitalization

NLSPW Stock  USD 0.01  0.01  83.33%   
Based on NLS Pharmaceutics' profitability indicators, NLS Pharmaceutics AG may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess NLS Pharmaceutics' ability to earn profits and add value for shareholders.

NLS Pharmaceutics Total Assets

3.34 Million

At this time, NLS Pharmaceutics' ROIC is fairly stable compared to the past year. ROE is likely to climb to 1.45 in 2024, whereas Book Value Per Share is likely to drop (0.24) in 2024.
For NLS Pharmaceutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NLS Pharmaceutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NLS Pharmaceutics AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NLS Pharmaceutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NLS Pharmaceutics AG over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NLS Pharmaceutics. If investors know NLS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NLS Pharmaceutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets
(2.28)
The market value of NLS Pharmaceutics is measured differently than its book value, which is the value of NLS that is recorded on the company's balance sheet. Investors also form their own opinion of NLS Pharmaceutics' value that differs from its market value or its book value, called intrinsic value, which is NLS Pharmaceutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NLS Pharmaceutics' market value can be influenced by many factors that don't directly affect NLS Pharmaceutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NLS Pharmaceutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NLS Pharmaceutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NLS Pharmaceutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

NLS Pharmaceutics Market Capitalization vs. Total Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining NLS Pharmaceutics's current stock value. Our valuation model uses many indicators to compare NLS Pharmaceutics value to that of its competitors to determine the firm's financial worth.
NLS Pharmaceutics AG is rated below average in total asset category among its peers. It is rated below average in market capitalization category among its peers creating about  20.46  of Market Capitalization per Total Asset. At this time, NLS Pharmaceutics' Total Assets are fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value NLS Pharmaceutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

NLS Market Capitalization vs. Total Asset

Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

NLS Pharmaceutics

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
1.85 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

NLS Pharmaceutics

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
37.77 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

NLS Market Capitalization vs Competition

NLS Pharmaceutics AG is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 2.39 Billion. NLS Pharmaceutics claims roughly 37.77 Million in market capitalization contributing just under 2% to equities under Health Care industry.
Capitalization  Valuation  Total debt  Workforce  Revenue

NLS Pharmaceutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in NLS Pharmaceutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NLS Pharmaceutics will eventually generate negative long term returns. The profitability progress is the general direction of NLS Pharmaceutics' change in net profit over the period of time. It can combine multiple indicators of NLS Pharmaceutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-158.1 K-150.2 K
Net Interest Income-145.2 K-152.4 K
Interest Income505.9 K681.3 K
Operating Income-11.8 M-12.4 M
Net Loss-12.2 M-12.8 M
Income Before Tax-12.2 M-12.8 M
Total Other Income Expense Net-365 K-383.2 K
Net Loss-3.3 M-3.5 M
Net Loss-12.2 M-12.8 M
Income Tax Expense 1.80  1.71 
Net Loss(0.32)(0.33)
Income Quality 0.80  0.52 

NLS Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on NLS Pharmaceutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NLS Pharmaceutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NLS Pharmaceutics' important profitability drivers and their relationship over time.

Use NLS Pharmaceutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NLS Pharmaceutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will appreciate offsetting losses from the drop in the long position's value.

NLS Pharmaceutics Pair Trading

NLS Pharmaceutics AG Pair Trading Analysis

The ability to find closely correlated positions to NLS Pharmaceutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NLS Pharmaceutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NLS Pharmaceutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NLS Pharmaceutics AG to buy it.
The correlation of NLS Pharmaceutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NLS Pharmaceutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NLS Pharmaceutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NLS Pharmaceutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your NLS Pharmaceutics position

In addition to having NLS Pharmaceutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Silver Thematic Idea Now

Silver
Silver Theme
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for NLS Stock Analysis

When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.